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Summary 
 
 Thirty-four Anaplasma marginale sero-
positive cows from a herd of 236 were allo-
cated to treatments: 5 animals served as un-
treated controls, and 29 animals were treated 
with three injections of long-acting oxytetra-
cycline at three-day intervals.  Fourteen days 
after initiation of treatment, 100% of control 
cows and 89% of treated cows were found to 
have Anaplasma marginale present.  Seventy-
four days after initiation of treatment, 100% of 
control cows and 86% of treated cows were 
found to have Anaplasma marginale present.  
Use of injectable long-acting oxytetracycline 
was not effective in eliminating the carrier 
state of Anaplasma marginale from infected 
animals.  
 
Introduction 
 
 Treatment with long-acting injectable 
oxytetracycline has long been recommended 
as one means of clearing the carrier state of 
Anaplasma marginale from infected cattle.  
Older diagnostic methods, such as the com-
plement-fixation test and card-agglutination 
test have indicated the success of such treat-
ment. Newer diagnostic methods, such as en-
zyme-linked immunosorbent assay (ELISA) 
and polymerase chain reaction (PCR) have 
enhanced the ability to assess the presence of 
antibodies to those organisms or the organ-
isms themselves. The objective of this study 
was to use ELISA and PCR diagnostic meth-
odologies to determine the efficacy of three 
injections of long-acting injectable oxytetra-
cycline.  
 
Experimental Procedures 
 
 A commercial cow herd of 236 animals 
was screened for antibodies to Anaplasma 
marginale by using the card-agglutination test; 
75 animals tested positive. Sixty-three of these 
75 animals were found to be positive for 
Anaplasma marginale when confirmatory test-
ing with both ELISA and PCR technology was 
conducted 20 days before the start of the study 
(day -20). Twenty-nine of the 63 positive 
animals were reserved for another study, and 
34 animals were included in this study. At the 
start of the study (day 0), 5 of the 34 animals 
were randomly allocated to a control group, 
and the remaining 29 were allocated to the 
oxytetracycline treatment group. On the basis 
of an average estimated weight of 1200 lb, 
animals in the oxytetracycline-treated group 
received 60 mL of a long-acting, injectable 
oxytetracycline product containing 200 
mg/mL oxytetracycline solution. All injections 
were given subcutaneously in the neck, with 
the 60 mL dose being distributed among four 
injection sites on one side of the neck on each 
treatment day. Treatment was repeated at 
three-day intervals for a total of three treat-
ments per animal.  Blood samples were taken 
from all animals 14 days after initiation of 
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treatment (day 14), and again 60 days later 
(day 74).  Blood samples were forwarded for 
PCR testing on day 14 and 74 and for ELISA 
testing on day 74.  
 
Results and Discussion 
 
 On day 14, 5 of 5 control animals (100%) 
and 25 of 28 oxytetracycline-treated animals 
(89%) were PCR positive for the presence of 
Anaplasma marginale organisms (Table 1).  
The sample from one oxytetracycline-treated 
cow was lost from the samples submitted for 
PCR testing on day 14.  ELISA testing was 
not conducted on samples collected on day 14 
because this testing method measures the sero-
logical status of animals, which was not ex-
pected to change that rapidly after death of 
Anaplasma marginale organisms.  On day 74, 
2 of 5 control animals (40%) and 16 of 29 
oxytetracycline-treated animals (55%) were 
ELISA positive for antibodies to Anaplasma 
marginale, whereas 5 of 5 control animals 
(100%) and 25 of 29 oxytetracycline-treated 
animals (86%) were PCR positive for the 
presence of Anaplasma marginale organisms.    
 
 All study animals had access to a free-
choice mineral mix containing 4.25 g chlortet-
racycline/lb mix during the period of mid-May 
through mid-October, before initial serological 
screening.  Consumption of the mineral mix 
during that period was approximately 0.25 lb 
cow daily.  Precautions were not taken to pre-
clude the needle-borne transmission of 
Anaplasma marginale during late-October 
herd vaccinations. Initial serological screening 
was completed during the months of Decem-
ber and January.  Study animals were not 
treated with any antimicrobial product by in-
jection or feed additive after initial screening 
or during the study period.  Precautions were 
taken to prevent the likelihood that needle-
borne transmission of Anaplasma marginale 
would occur during springtime vaccinations.  
Day 14 blood samples were drawn before the 
start of the biting fly season, when Anaplasma 
marginale transmission could occur.  Day 74 
blood samples were drawn after the biting fly 
season was under way. 
 
 Repeated injections of long-acting oxytet-
racycline were not effective in eliminating the 
carrier state of Anaplasma marginale from 
infected animals (Table 1).  PCR testing was 
able to detect the presence of Anaplasma mar-
ginale organisms even when ELISA testing 
did not detect serological evidence of their 
presence (Table 1). 
 
 The declining ELISA results from day -20 
to day 74 in both control and oxytetracycline-
treated animals (Table 1) were unexpected and 
suggested a degree of non-treatment-related 
recovery or reversion to non-seropositive 
status in both groups.  However, the PCR re-
sults indicated that Anaplasma marginale or-
ganisms were present on both day 14 and day 
74.  If treatment with three injections of long-
acting oxytetracyline had been successful in 
eliminating the carrier state of Anaplasma 
marginale, PCR test results were expected to 
have been negative on both test dates.  
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Table 1.  Lack of Efficacy of Treatment with Long-Acting Oxytetracycline as Indicated by 
Number and Percentage of Animals Still Positive for Anaplasma marginale on the Basis of 
ELISA and PCR Testing on Each Study Day 
 Control  Long-Acting Oxytetracycline 
 ELISA PCR ELISA PCR 
Study Day Positive (%) Positive (%) Positive (%) Positive (%) 
−20 5/5 (100) 5/5 (100) 29/29 (100) 29/29 (100) 
14  5/5 (100)  25/28 (89) 
74 2/5 (40) 5/5 (100) 16/29 (55) 25/29 (86) 
 
